This week on Contemporary OB/GYN®: Oct. 25 to Oct. 29
Here's a preview of what to expect this week from Contemporary OB/GYN®.
Pink October video shines light on women’s health — and their right to know prices
Every October, the pink ribbons and flamingoes come out to raise breast cancer awareness. However, Pink October should go beyond breast cancer awareness to shine the light on women’s health overall, and, as important, the huge responsibility women bear as chief decision-makers for their families’ health care.
Agenus Withdraws BLA for Balstilimab in Metastatic Cervical Cancer
The immuno-oncology company Agenus has made the decision to withdraw its biologic license application for the use of the PD-1 inhibitor balstilimab in patients with recurrent or metastatic cervical cancer who experienced disease progression on, or after, chemotherapy.
Poll: Have you attended an in-person conference recently?
Check back soon for additional updates.
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
